Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		5 Months Ended	7 Months Ended	12 Months Ended	19 Months Ended
	Dec. 31, 2024	Dec. 31, 2024	Jul. 30, 2024	Dec. 31, 2023	Jul. 30, 2024
Cash flows from operating activities:
Net loss		$ (53,763)	$ (21,278)	$ (36,590)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		740	646	532
Non-cash operating lease expense		56	98	159
Stock-based compensation			642	442
Provision for inventory impairment		(4)	15	25
Amortization of term loan discount			10	16
Loss on disposal of property and equipment			62	3
Impairment - Goodwill		30,324	0	0	$ 0
Impairment - Intangibles, net		18,878
Change in fair value of convertible notes payable		(929)	(2,059)	6,930
Change in fair value of warrant liabilities		(6,576)	(191)	42
Net change in operating assets and liabilities:
Accounts receivable, net		67	(32)	(70)
Inventory, net		1,399	(773)	(2,976)
Prepaid expenses and other current assets		(886)	(95)	410
Accounts payable		(1,933)	(2,628)	2,821
Accrued liabilities		127	511	886
Accrued transaction costs		3	7,446	444
Other accrued liabilities		1,001	1,734	1,435
Operating lease liabilities		(56)	(98)	(161)
Deferred taxes		(1,917)
Net cash used in operating activities		(13,469)	(15,990)	(25,652)
Cash flows from investing activities:
Purchases of property and equipment		(1,280)	(368)	(333)
Purchases of software				(7)
Net cash used in investing activities		(1,280)	(368)	(340)
Cash flows from financing activities:
Proceeds from exercise of common stock options				18
Proceeds from issuance of convertible notes payable			16,500	20,000
Proceeds from term loan				3,000
Repayment of non-convertible term loan			(867)	(1,143)
Net cash provided by financing activities			15,633	21,875
Effect of foreign currency translation on cash and cash equivalents		181	24	(47)
Net change in cash and cash equivalents		(14,568)	(701)	(4,164)
Cash and cash equivalents, at beginning of period		35,154	1,383	5,547	5,547
Cash and cash equivalents, at end of period	$ 20,586	$ 20,586	35,154	1,383	35,154
Supplemental disclosure of cash flow information:
Cash paid for interest			85	208
Supplemental disclosure of noncash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities			(216)
Lease liabilities recorded for operating lease right-of-use assets			216
Amount of term loan proceeds allocated to warrant liabilities				$ 36
Exchange preferred stock for pre-funded warrants			$ 4,332
Financial Designation, Predecessor and Successor [Fixed List]	Successor	Successor	Predecessor	Predecessor
Prior to Effect of Business Combination
Cash flows from financing activities:
Cash and cash equivalents, at beginning of period		$ 682
Cash and cash equivalents, at end of period			$ 682		$ 682